... Complementary and Alternative Medicine andMultipleSclerosis Second Edition This page intentionally left blank Complementary and Alternative Medicine andMultipleSclerosis Second Edition ... title Alternative Medicine andMultipleSclerosis Library of Congress Cataloging-in-Publication Data Bowling, Allen C Complementary and alternative medicine andmultiplesclerosis Allen C Bowling—2nd ... Alternative medicine andmultiplesclerosis c2001 Includes bibliographical references and index ISBN-13: 978-1-932603-54-5 (pbk : alk paper) ISBN-10: 1-932603-54-9 (pbk : alk paper) Multiplesclerosis Alternative...
... the clinical course of multiple sclerosis: Results of an international survey National multiplesclerosis society (USA) advisory committee on clinical trials of new agents in multiplesclerosis ... intensity and catastrophizing in individuals with multiplesclerosisand chronic pain Int J Clin Exp Hypn Jan 2011; 59(1):45–63 Krupp LB Fatigue in multiple sclerosis: Definition, pathophysiology and ... mood and affect in multiplesclerosisMultiplesclerosis therapeutics New York: Martin Dunitz; 2003:651–89 Sadovnick AD, Eisen K, Ebers GC, Paty DW Cause of death in patients attending multiple sclerosis...
... MULTIPLESCLEROSIS CURRENT STATUS AND STRATEGIES FOR THE FUTURE Janet E Joy and Richard B Johnston, Jr., Editors Committee on Multiple Sclerosis: Current Status and Strategies ... disease, causes, course, and treatments (Chapters 2, 5, and 6); (2) adaptation and management (combination of medical, technological, and psychosocial aspects) (Chapters and 4); and finally, (3) ... bibliographical references and index ISBN 0-309-07285-9 (hardcover) Multiplesclerosis [DNLM: MultipleSclerosis therapy MultipleSclerosis physiopathology Research WL 360 M956378 2001] I Joy, Janet...
... factors" , mainly genomic alterations of CLL cells, and "extrinsic factors" , responsible for direct micro-environmental interactions of CLL cells Intrinsic factors Under the terms "intrinsic factors" ... [4], and it is more common among patients bearing other poor prognostic factors, such as UM IGHV, or ZAP-70 and CD38 expression [4,10,27,30] TP53 is a transcription factor activated by strand ... Translational Medicine 2009, 7:76 IG(K/L)V and IG(K/L)J segments Both for heavy and light chains, the segments involved in V(D)J recombination confer diversity by random and imprecise rearrangement during...
... and leisure IPAQ score and the BDI, and all subscales of MFIS and SF36 were performed Univariate analysis between disease severity, exercise status and the BDI and all subscales of the MFIS and ... of persons with multiple sclerosis: the possible warning signs Mult Scler 2007, 13(8):1038-1045 MultipleSclerosis Council for Clinical Practice Guidelines: Fatigue andmultiple sclerosis: evidence-based ... psychological group therapy in patients with multiplesclerosis Acta Neurol Scand 2003, 107(6):394-399 Motl RW, McAuley E, Snook EM: Physical activity andmultiple sclerosis: a meta-analysis Mult Scler...
... as an internal standard The coefficient of variation of intra- and interassay determinations for trp and kyn was below 5% Recovery of trp and kyn was determined by measuring trp and kyn in 20 μl ... marker of disease activity in multiplesclerosis Brain 1997, 120(Pt 1):1-13 Sorensen PS: Biological markers in body fluids for activity and progression in multiplesclerosis Mult Scler 1999, 5:287-290 ... Weinstock-Guttman B, Herndon RM, et al: Incidence and significance of neutralizing antibodies to interferon beta-1a in multiplesclerosisMultipleSclerosis Collaborative Research Group (MSCRG)...
... in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 1983, 33(11):1444-1452 MultipleSclerosis Council for Clinical Practice Guidelines: Fatigue andmultiple sclerosis: ... Toyka KV: Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters Multiplesclerosis (Houndmills, Basingstoke, England) 2002, 8(6):523-526 ... assessment of fatigue in MS? Multiplesclerosis (Houndmills, Basingstoke, England) 2005, 11(2):198-202 Jackson MF, Quaal C, Reeves MA: Effects of multiplesclerosis on occupational and career patterns...
... of soluble HLA-I and soluble HAL-II Drs Minagar and Kelley have contributed to this manuscript by recruiting and examining multiplesclerosis patients, interpretation of data and preparing the ... assay included a standard curve derived from positive and negative controls Negative controls consisted of 2% BSA and human serum, free of sHLA-I and sHLA-II Positive control standards were prepared ... realm, there is a possible alteration of sHLA-I and/ or sHLA-II levels as a reflection of disease activity in multiplesclerosis (MS) Clinical and brain magnetic resonance imaging (MRI) disease...
... expression and distinct regulation of pro- and secreted IL-16 in acute, subacute and chronic MS lesions, and in normal-appearing white matter, from brain and spinal cord of 39 patients with MS and 19 ... binding proteins in multiplesclerosis plaques Neuropath and App Neurobio 1999, 25:215-25 Gveric D, Herrera BM, Cuzner ML: Receptors and the Fibrinolytic Response in MultipleSclerosis Lesions ... BD: Axonal degeneration and progressive neurology disability in multiplesclerosis Neurotox Res 2003, 5:157-64 Lassmann H, Bruck W, Lucchinetti C: Heterogeneity of multiplesclerosis pathogenesis:...
... acid and lysophospholipids and therefore also control levels of inflammatory mediators and cytotoxic metabolites including prostaglandins, leukotrienes, and reactive oxygen species PLA2 enzymes and ... infiltration and activation during Wallerian degeneration and axonal regeneration J Neurosci 1998, 18(17):6713-6722 Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability ... supported by grant PP1055 from the National MultipleSclerosis Society 23 References 10 11 12 13 14 15 16 17 18 19 20 Prat A, Antel J: Pathogenesis of multiplesclerosis Curr Opin Neurol 2005, 18(3):225-230...
... methods and Table S1 Acknowledgements Support from the National MultipleSclerosis Society (RG3743 and a Pediatric MS Center of Excellence Center Grant) and the Department of Defense MultipleSclerosis ... MMP-8, MMP-9, IL-12p40 and IL-23 in multiplesclerosis patients treated with interferon-beta1b Mult Scler 2010, 16:801-809 29 Minagar A, Jy W, Jimenez JJ, Alexander JS: Multiplesclerosis as a vascular ... volumes and brain atrophy in multiplesclerosis Neurology 2009, 73:504-510 27 Jorgensen B, Tsao M: Dispersion models and longitudinal data analysis Stat Med 1999, 18:2257-2270 28 Alexander JS,...
... wards, lack of space and privacy) and associated factors (e.g staff and patient interactions) [17] The effects of aggression and violent behaviour are equally wide and diverse and may negatively ... turnover, and reduced trust of management and co-workers, and a hostile working environment [30] Under the strain of reforms, growing work pressure and stress, social instability, and the deterioration ... Morocco: prevalence, predictive factors, and psychological impact Journal of Occupational Medicine and Toxicology 2010 5:27 Submit your next manuscript to BioMed Central and take full advantage...
... as an internal standard The coefficient of variation of intra- and interassay determinations for trp and kyn was below 5% Recovery of trp and kyn was determined by measuring trp and kyn in 20 μl ... marker of disease activity in multiplesclerosis Brain 1997, 120(Pt 1):1-13 Sorensen PS: Biological markers in body fluids for activity and progression in multiplesclerosis Mult Scler 1999, 5:287-290 ... Weinstock-Guttman B, Herndon RM, et al: Incidence and significance of neutralizing antibodies to interferon beta-1a in multiplesclerosisMultipleSclerosis Collaborative Research Group (MSCRG)...
... Reliability and Validity The distributional properties of the PRIMUS and U-FIS were explored through descriptive statistics (mean, standard deviation, median and inter-quartile range [IQR]) and floor and ... depression in multiplesclerosis a population based perspective Neurology 2003, 61:1524-27 Montel SR, Bungener C: Coping and quality of life in one hundred and thirty five subjects with multiplesclerosis ... previous years), Expanded Disability Status Scale (EDSS) score of between and 5.5 and neurologically stable for at least 30 days prior to randomization Twiss et al Health and Quality of Life...
... and leisure IPAQ score and the BDI, and all subscales of MFIS and SF36 were performed Univariate analysis between disease severity, exercise status and the BDI and all subscales of the MFIS and ... of persons with multiple sclerosis: the possible warning signs Mult Scler 2007, 13(8):1038-1045 MultipleSclerosis Council for Clinical Practice Guidelines: Fatigue andmultiple sclerosis: evidence-based ... psychological group therapy in patients with multiplesclerosis Acta Neurol Scand 2003, 107(6):394-399 Motl RW, McAuley E, Snook EM: Physical activity andmultiple sclerosis: a meta-analysis Mult Scler...
... homocysteine (Hcy) and vitamin B12 in multiplesclerosis (MS) patients and controls Box and1 Box and whisker plot of plasma homocysteine (Hcy) and vitamin B12 in multiplesclerosis (MS) patients and controls ... anxiety and depression in multiplesclerosis outpatients Acta Neurol Scand 2007, 115:67-72 Provinciali L, Ceravolo MG, Bartolini M, Logullo F, Danni M: A multidimensional assessment of multiple sclerosis: ... of the study, and participated in its design and coordination, carried out the statistical analysis and drafted the manuscript MEE and VKK participated in the design of the study and drafted the...
... of the angiogenic factors VEGF and bFGF and an increase of the angiostatic factor endostatin contribute to the impaired angiogenesis in patients with SSc, and whether these factors may correlate ... endostatin and bFGF and other clinical parameters No correlation of VEGF, endostatin and bFGF levels with skin score, carbon monoxide diffusion capacity and the presence of teleangiectasias and other ... levels of (a) endostatin and (b) basic fibroblast growth factor (bFGF) in patients with established systemic sclerosis (SSc) and in healthy controls Levels of endostatin and bFGF were not enhanced...
... and AG conceived of the study, implemented the technology, and participated in its design and coordination and drafted the manuscript MS and MT participated in the coordination of the study and ... including tumor histology and location, tissue consistency and texture, patients' age and sex Statistical evaluation included Student's t test with paired and unpaired comparisons and Fisher's exact ... different electrode tips (1 and mm ball, and mm ring, needle, and blade) The ball and ring tips are malleable The electrode shafts are supplied in a long (95–100 mm) and in a short (55–60 mm) version...
... with discrimination of the factors concerning rectal bleeding, bowel incontinence and irritative symptoms Patient-related and dose-volume-related factors were tested for a predictive value, respectively ... Radiation Units and Measurements (ICRU): ICRU Report 50: Prescribing, recording and reporting photon beam therapy Bethesda, MD: ICRU; 1993 Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG, Wei JT, ... RL, Litwin MS, Sandler HM, Sanda MG, Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG: Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment...
... O’reilly EJ, Levin LI, Berger T, Ascherio A: Myelin oligodendrocyte glycoprotein antibodies andmultiplesclerosis in healthy young adults Neurology 2008, 71:1142-1146 Kuhn KA, Kulik L, Tomooka ... Therapy Vol 10 No Lundberg and Venables reported in one previous study of collagen-induced arthritis [5], though other studies have found equal binding to both citrullinated and arginine-containing ... work is often regarded as hypothesisgenerating rather than hypothesis-testing The study from Kidd and colleagues [1] falls in the former group, in that it provides more questions than answers In...